<DOC>
	<DOCNO>NCT02772965</DOCNO>
	<brief_summary>The purpose study determine whether add low dose methotrexate anti -TNF therapy effective treatment anti-TNF therapy alone induce maintain steroid-free remission child Crohn 's Disease .</brief_summary>
	<brief_title>Low Dose Oral Methotrexate Pediatric Crohn 's Disease Patients Initiating Anti-Tumor Necrosis Factor ( Anti-TNF ) Therapy</brief_title>
	<detailed_description>Overall study duration : 4 year Multi-center study : 50 center Number subject : 425 Duration treatment subject : 104 week ( 2 year ) The primary endpoint time treatment failure .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Pediatric Crohn 's Disease ( PCD ) patient , &lt; 21 year age , â‰¥20 kg , initiate antiTNF therapy infliximab adalimumab . Diagnosis Crohn 's Disease ( CD ) establish confirm treat clinician , establish standard clinical criterion ( radiography , endoscopy , histology ) . Ability provide parental permission child assent ( applicable ) , adult consent patient age 1820 . Prior use antiTNF biological therapy CD Inability swallow pill Lack stable home address study medication mail Anticipated short length follow study center ( plan family move , transition adult GI ( gastrointestinal ) provider , etc. ) . Patients expect leave practice &lt; 24 month enrollment enrol . Abdominal abscess within last 3 month Prior intraabdominal surgery without clinically significant relapse ( i.e . patient start antiTNF postop prophylaxis endoscopic recurrence include ) Receipt live virus vaccine within last 30 day Pregnancy , plan become pregnant , high risk pregnancy determine local investigator Breastfeeding Refusal stay abstinent utilize 2 form birth control study medication ( female patient ) BMI &gt; 95 % gender age Known previous concurrent malignancy ( consider surgically cure , evidence recurrence 5 year ) . A recent history basal cell squamous cell carcinoma , consider surgically cure , exclude subject.Those recent history colonic adenoma dysplastic lesion exclude . Known high alcohol consumption ( seven drink per week ) Patients serum albumin &lt; 2.5 g/dl baseline Patients white blood cell count ( WBC ) &lt; 3.0 x109th/L baseline Patients platelet count &lt; 100 x109th/L Patients initial elevation liver enzyme ( AST ALT ) &gt; 1.5 time normal limit baseline Patients know C. difficile screen visit Patients preexist hepatic disease Patients preexist renal dysfunction ( creatinine &gt; 0.8 child age &lt; 10 , creatinine &gt; 1.2 mg/dl child age 1018 , creatinine &gt; 1.5 mg/dl adult age 18 year old ) . Patients preexist chronic lung disease well control asthma Current treatment one follow drug : Probenecid ( Probalan ) , Acitretin ( Soriatane ) , Streptozocin ( Zanosar ) , Azathioprine ( Imuran , Azasan ) , 6mercaptopurine ( Purinethol , Purixan ) Other concern patient/family 's ability participate study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>